tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Compare Editas Medicine (EDIT) vs. Competitors

Compare
3,557 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$2.54
$248.59M
-1.14
73.97%
3 Buy
2 Hold
2 Sell
Hold
Cellectis SA
$3.50
$257.66M
121.36
182.26%
1 Buy
1 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$4.90
$291.74M
-4.58
12.19%
9 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$12.20
$223.70M
-3.08
56.90%
3 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$13.51
$571.31M
-0.10
-23.17%
4 Buy
0 Hold
0 Sell
Strong Buy
Caribou Biosciences
$1.87
$180.71M
-1.42
85.15%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.54
1.13
80.14%
CLLS
Cellectis SA
3.50
2.28
186.89%
FHTX
Foghorn Therapeutics
4.97
0.37
8.04%
ELTX
Elicio Therapeutics
12.16
4.26
53.92%
VOR
Vor Biopharma
13.76
-3.45
-20.05%
CRBU
Caribou Biosciences
1.87
0.85
83.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts